Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled phase 3 study of pravastatin in advanced gastroesophageal cancer
2009-013928-23Phase 3Active
- Sponsor
- Luis Bujanda Fernández de Piérola
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of pravastatin in esophagogastric junction cancer (2 arms), sponsored by Luis Bujanda Fernández de Piérola. Primary endpoints: Overall survival, Disease progression and 2 more. Started Dec 2009; status: active.
02
Drugs
pravastatin
03
Conditions
esophagogastric junction cancer
Beyond the preview
Go deeper on 2009-013928-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013928-23.